CLINICAL ROLE -
Oncology Overview: Discovering the Therapeutic Value of Osimertinib Targeted Therapy
Osimertinib (Tagrisso; AstraZeneca) is FDA approved for 3 unique cancer indications.
Read More
Looking Ahead: Trends in Breast Cancer Care in 2022
An emerging focus is aligning targeted, safe, and effective therapies with patient goals.